Biofil Chemicals & Pharmaceuticals Limited — Important, 11-02-2025: Updates

Biofil Chemicals and Pharmaceuticals Limited is set to sell a significant asset, comprising plant, machinery, and other equipment, to Cyano Pharma Private Limited, a related party. This undertaking contributed a substantial ₹27.87 Crore to the company's total turnover, accounting for approximately 69.61%. The net worth from this segment was ₹9.33 Crore, representing 64.81% of total net worth.

The anticipated completion of the sale is on or before June 30, 2025, pending shareholder approval, which is being sought through postal ballot. The board has set a minimum consideration of ₹2.15 Crore for this transaction. While a previous agreement was mutually canceled due to space constraints, the current deal is still under negotiation and will adhere to arm's length principles. This move signals a strategic shift for the firm, with potential positive implications for its operational focus moving forward. Investors should watch closely for updates on this transaction.